CTI Clinical Trial & Consulting Services is a global, privately held, research service organization, delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s therapeutic focus provides pharmaceutical, biotechnology, and medical device firms with expertise in various therapeutic areas. As a leader in the rare disease field, CTI is patient-centric and adept at navigating the intricacies of this research. Having contributed to more than 150 rare disease studies, CTI focuses on cutting-edge medical research to advance the development of these novel treatments. CTI also offers a multi-specialty clinical research site and global laboratory services. Now in its third decade, CTI ranks among the top 20 CROs.